These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20060937)

  • 21. Preparation and characteristics of a calcium magnesium silicate (bredigite) bioactive ceramic.
    Wu C; Chang J; Wang J; Ni S; Zhai W
    Biomaterials; 2005 Jun; 26(16):2925-31. PubMed ID: 15603787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fabrication and characterization of bioactive wollastonite/PHBV composite scaffolds.
    Li H; Chang J
    Biomaterials; 2004 Nov; 25(24):5473-80. PubMed ID: 15142728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosilicate nanocomposite: a novel resorbable bioactive tissue engineering scaffold for BMP and bone-marrow cell delivery.
    El-Ghannam A; Ning CQ; Mehta J
    J Biomed Mater Res A; 2004 Dec; 71(3):377-90. PubMed ID: 15470721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A novel europium doped apatite/wollastonite porous magnetic bioactive glass ceramic].
    Zhang W; Zhou D; Yang W; Yin G; Ou J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Aug; 24(4):785-9. PubMed ID: 17899745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ca,P-rich layer formed on high-strength bioactive glass-ceramic A-W.
    Kokubo T; Ito S; Huang ZT; Hayashi T; Sakka S; Kitsugi T; Yamamuro T
    J Biomed Mater Res; 1990 Mar; 24(3):331-43. PubMed ID: 2156869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural studies of bioactivity in sol-gel-derived glasses by X-ray spectroscopy.
    Skipper LJ; Sowrey FE; Pickup DM; Fitzgerald V; Rashid R; Drake KO; Lin Z; Saravanapavan P; Hench LL; Smith ME; Newport RJ
    J Biomed Mater Res A; 2004 Aug; 70(2):354-60. PubMed ID: 15227682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of thermal treatment on the "in vitro" bioactivity of wollastonite materials.
    de la Casa-Lillo MA; Velásquez P; De Aza PN
    J Mater Sci Mater Med; 2011 Apr; 22(4):907-15. PubMed ID: 21336850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological and antibacterial properties of plasma sprayed wollastonite coatings grafting gentamicin loaded collagen.
    Li B; Liu X; Cao C; Dong Y; Wang Z; Ding C
    J Biomed Mater Res A; 2008 Oct; 87(1):84-90. PubMed ID: 18085657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxyapatite/SiO(2)-CaO-P(2)O(5) glass materials: in vitro bioactivity and biocompatibility.
    Padilla S; Román J; Sánchez-Salcedo S; Vallet-Regí M
    Acta Biomater; 2006 May; 2(3):331-42. PubMed ID: 16701892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase composition and in vitro bioactivity of porous implants made of bioactive glass S53P4.
    Fagerlund S; Massera J; Moritz N; Hupa L; Hupa M
    Acta Biomater; 2012 Jul; 8(6):2331-9. PubMed ID: 22409875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-CaSiO3/beta-Ca3(PO4)2 composite materials for hard tissue repair: in vitro studies.
    Ni S; Lin K; Chang J; Chou L
    J Biomed Mater Res A; 2008 Apr; 85(1):72-82. PubMed ID: 17688291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro bioactivity and biocompatibility of dicalcium silicate cements for endodontic use.
    Chen CC; Ho CC; David Chen CH; Wang WC; Ding SJ
    J Endod; 2009 Nov; 35(11):1554-7. PubMed ID: 19840646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioactivity of CaSiO3/poly-lactic acid (PLA) composites prepared by various surface loading methods of CaSiO3 powder.
    Okada K; Hasegawa F; Kameshima Y; Nakajima A
    J Mater Sci Mater Med; 2007 May; 18(5):899-907. PubMed ID: 17216578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro bioactivity and degradation of polycaprolactone composites containing silicate fillers.
    Chouzouri G; Xanthos M
    Acta Biomater; 2007 Sep; 3(5):745-56. PubMed ID: 17392042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of silica sol on the microstructure and mechanical properties of CaSiO3 bioceramics.
    Pan Y; Yin J; Yao D; Zuo K; Xia Y; Liang H; Zeng Y
    Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():336-340. PubMed ID: 27127061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fabrication of Poly-(DL-Lactic Acid)--Wollastonite Composite Films with Surface Modified {beta}-CaSiO3 Particles.
    Lingzhi Ye ; Jiang Chang ; Congqin Ning ; Kaili Lin
    J Biomater Appl; 2008 Mar; 22(5):465-80. PubMed ID: 17623708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of SBF with different HCO3- content and its influence on the composition of biomimetic apatites.
    Müller L; Müller FA
    Acta Biomater; 2006 Mar; 2(2):181-9. PubMed ID: 16701876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactivity of electro-thermally poled bioactive silicate glass.
    Mariappan CR; Yunos DM; Boccaccini AR; Roling B
    Acta Biomater; 2009 May; 5(4):1274-83. PubMed ID: 19097952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioactive glass sol-gel foam scaffolds: Evolution of nanoporosity during processing and in situ monitoring of apatite layer formation using small- and wide-angle X-ray scattering.
    FitzGerald V; Martin RA; Jones JR; Qiu D; Wetherall KM; Moss RM; Newport RJ
    J Biomed Mater Res A; 2009 Oct; 91(1):76-83. PubMed ID: 18767060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of a simulated inflammation procedure in simulated body fluid on bone-like apatite formation on porous HA/beta-TCP bioceramics].
    Ji J; Ran J; Gou L; Wang F; Sun L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):531-5. PubMed ID: 15357425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.